The association between complementary and alternative medicine use with breast cancer recurrence in Taif city, Saudi Arabia

Sahar M. Alnefaie; Yousif A. Asiri; Razan S. Alqahtani; Maha O. Alshareef; Khalid M. Alzahrani; Sarah M. Albogami

doi:10.18203/2349-2902.isj20240314

Authors

Sahar M. Alnefaie Department of Surgery, College of Medicine, Taif University, Al-Taif, Saudi Arabia
Yousif A. Asiri Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia
Razan S. Alqahtani Taif University, Taif, Saudi Arabia
Maha O. Alshareef Taif University, Taif, Saudi Arabia
Khalid M. Alzahrani Department of General Surgery, Taif University, Taif, Saudi Arabia
Sarah M. Albogami Department of Biotechnology, College of Science, Taif University, Taif, Saudi Arabia

DOI:

https://doi.org/10.18203/2349-2902.isj20240314

Keywords:

Complementary, Alternative medicine, BC, Recurrence

Abstract

Background: Breast cancer (BC) is the most common cancer among women worldwide. Among all types of cancer, 11.7% of cases diagnosed in 2020 were BC. Compare this to Saudi Arabia, where 28.8 out of every 100,000 women were diagnosed with BC. Furthermore, BC patients are more likely than other cancer survivors to use complementary and alternative medicine (CAM). Study aimed to investigate association between CAM use and BC recurrence rates in Saudi Arabia.

Methods: A cross-sectional study was conducted on 106 participants recruited from breast surgery clinics. Targeted women were diagnosed with BC and treated at Al Hada armed forces hospital. The data were collected by interviewing the patients using a validated questionnaire.

Results: The prevalence of CAM usage among BC patients was 35.8%. The recurrence rate of BC was 26.4%. CAM users accounted for 28.57% of the total, while non-CAM users comprised 71.43%. In addition, 50% of recurrences were distant metastases, and 50% occurred more than two years after diagnosis.

Conclusions: In conclusion, more than one-third of BC patients in this region incorporate CAM into their treatment regimen. Our findings reveal a practical but not statistical significance of a lower recurrence rate of BC among CAM users compared to non-CAM. These results emphasize the importance of healthcare providers engaging in detailed discussions with BC patients regarding CAM usage in conjunction with planned medical and surgical therapies.

Metrics

Metrics Loading ...

References

Cancer Today-Global Cancer Observatory, International Agency for Research on Cancer, WHO reports, 2020. Available at: https://gco.iarc.fr/today/. Accessed on 3 January 2024.

Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:4.

National Center for Complementary and Integrative Health. U.S. Department of Health and Human. Available at: https://www.nccih.nih.gov/. Accessed on 3 January 2024.

Kim EEH, Kang J. Association between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence among Breast Cancer Survivors. Korean J Fam Med. 2022;43(2):132-40.

Chang EY, Glissmeyer M, Tonnes S, Hudson T, Johnson N. Outcomes of breast cancer in patients who use alternative therapies as primary treatment. Am J Surg. 2006;192(4):471-3.

Rakovitch E, Pignol JP, Chartier C, Ezer M, Verma S, Dranitsaris G, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat. 2005;90(2):139-48.

Carpenter CL, Ganz PA, Bernstein L. Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat. 2009;116(2):387-96.

Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92(1):42-7.

Albabtain H, Alwhaibi M, Alburaikan K, Asiri Y. Quality of life and complementary and alternative medicine use among women with breast cancer. Saudi Pharm J. 2018;26(3):416-21.

Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, Buiatti E. The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer. 1998;34(3):324-8.

Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 2008;113(5):1048-57.

Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000;18(13):2515-21.

Adler SR. Complementary and alternative medicine use among women with breast cancer. Med Anthropol Q. 1999;13(2):214-22.

Eschiti VS. Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies. Integr Cancer Ther. 2007;6(4):313-44.

Greenlee H, Kwan ML, Ergas IJ, Sherman KJ, Krathwohl SE, Bonnell C, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009;117(3):653-65.

Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat. 2006;100(2):219-27.

National Center for Complementary and Alternative Medicine (NCCAM). The Use of Complementary and Alternative Medicine in the United States. Available at: https://files.nccih.nih.gov/s3fs-public/camuse.pdf. Accessed on 3 January 2024.

Abuzenada BM, Pullishery F, Elnawawy MSA, Alshehri SA, Alostath RMB, Bakhubira BM, et al. Complementary and Alternative Medicines in Oral Health Care: An Integrative Review. J Pharm Bioallied Sci. 2021;13(2):S892-7.

Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann Intern Med. 1984;101(1):105-12.

Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994;309(6947):86-9.

Maher EJ, Young T, Feigel I. Complementary therapies used by patients with cancer. BMJ. 1994;309(6955):671-2.

Cassileth BR, Chapman CC. Alternative and complementary cancer therapies. Cancer. 1996;77(6):1026-34.

Yang G, Zhang H, Gan Z, Fan Y, Gu W, Ling C. Discrepant Views of Oncologists and Cancer Patients on Complementary and Alternative Medicine in a Chinese General Hospital. Integr Cancer Ther. 2018;17(2):451-7.